SLX-1046

N/A

Report date: 2023/11/07 14:45:59
NME

Base Information

Drug NameSLX-1046
Drug Alias NameSLX-1046
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionEukaryotic translation initiation factor 2-alpha kinase 4 modulators
TargetsEukaryotic translation initiation factor 2-alpha kinase 4
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBiolexis Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesBiolexis Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A